Abstract
The estrogen receptor (ER) is a well-known predictor of breast cancer response to endocrine therapy. ER+ progesterone receptor (PR)- breast tumors have a poorer response to endocrine therapy and a more aggressive phenotype than ER+PR+ tumors. A comparative genomic hybridization array technique was used to examine 25 ER+PR+ and 23 ER+PR- tumors. Tissue microarrays composed of 50 ER+PR+ and 50 ER+PR- tumors were developed to validate the comparative genomic hybridization array results. The genes of interest were analyzed by fluorescence in situ hybridization. The ER+PR- group had a slightly different genomic profile when compared with ER+PR+ tumors. Chromosomes 17 and 20 contained the most overlapping gains, and chromosomes 3, 8, 9, 14, 17, 21, and 22 contained the most overlapping losses when compared with the ER+PR+ group. The gained regions, 17q23.2-q23.3 and 20q13.12, and the lost regions, 3p21.32-p12.3, 9pter-p13.2, 17pter-p12, and 21pter-q21.1, occurred at different alteration frequencies and were statistically significant in the ER+PR- tumors compared with the ER+PR+ tumors. ER+PR- breast tumors have a different genomic profile compared with ER+PR+ tumors. Differentially lost regions in the ER+PR- group included genes with...Continue Reading
References
Nov 1, 1978·Endocrinology·K B HorwitzW L McGuire
Jun 15, 1980·Cancer·N D BloomG A Degenshein
Sep 1, 1996·The Journal of Pathology·I P TomlinsonW F Bodmer
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Nov 26, 1998·The New England Journal of Medicine·C K Osborne
Aug 3, 2000·Journal of the National Cancer Institute·M BärlundA Kallioniemi
Mar 10, 2001·Experimental Cell Research·J W Rocco, D Sidransky
Sep 29, 2001·Molecular Pathology : MP·A MartinezF Latif
Aug 31, 2002·Journal of Human Genetics·Qifeng YangKennichi Kakudo
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valerie-Jeanne BardouGary M Clark
Dec 2, 2004·Bioinformatics·Paul H C Eilers, Renée X de Menezes
Sep 8, 2005·Journal of the National Cancer Institute·Grazia ArpinoRichard M Elledge
Oct 6, 2005·Human Molecular Genetics·Guiqing HuangColin Collins
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Mar 25, 2006·Cell Death and Differentiation·J A Royds, B Iacopetta
Jul 21, 2006·Cell Cycle·Anupama E GururajRakesh Kumar
Dec 13, 2006·Cancer Cell·Koei ChinJoe W Gray
May 30, 2007·Oncogene·L B HessonF Latif
Jun 19, 2007·Biochimica Et Biophysica Acta·Kate G R QuinlanMerlin Crossley
Aug 11, 2007·The EMBO Journal·Yi-Hung OuSheau-Yann Shieh
Mar 13, 2008·Genes, Chromosomes & Cancer·Peter M HavertyJohn Chant
Apr 22, 2008·Breast Cancer Research and Treatment·Chad J CreightonRachel Schiff
Jul 22, 2008·Medicinal Research Reviews·George G ChenGary Mk Tse
Jul 26, 2008·BMC Genomics·Henna HeinonenOuti Monni
Apr 28, 2011·Cancer·Min FangKevin Claffey
Citations
Oct 16, 2015·Pediatric Blood & Cancer·Robert Tanner HagelstromPeter F Coccia
Feb 7, 2014·Biomarker Research·Linping HuWeimin Miao
May 18, 2016·International Journal of Molecular Sciences·Simona GranataGianluigi Zaza
Jul 13, 2016·British Journal of Cancer·Federico RojoPilar Eroles
Oct 22, 2016·Cell Communication and Signaling : CCS·Susan M FarabaughAdrian V Lee
Oct 26, 2012·The New England Journal of Medicine·Clemens Tempfer